bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.10.13.758904

Cytoplasmic recapping commences the translation of a micropeptide, MARS from MALAT1 after the removal of an inhibitory RNA G-quadruplex

Abstract

Long non-coding RNAs (lncRNAs), conventionally defined as RNA transcripts longer than 200 nucleotides that lack protein-coding potential, have emerged as key regulators of diverse biological processes, including metabolism, development, cellular differentiation, and stress responses. They modulate cellular functions through multiple mechanisms, including chromatin remodeling, transcriptional regulation, and the control of RNA stability and translation. Most lncRNAs are transcribed by RNA polymerase II and undergo canonical RNA processing, including splicing, polyadenylation, and 5' N7-methylguanosine (mG) capping. However, whether cytoplasmic recapping of lncRNAs can promote the production of functional micropeptides remains poorly understood. In this study, we investigated the functional consequences of cytoplasmic recapping of MALAT1, a highly abundant and broadly expressed lncRNA. We demonstrate that cytoplasmic processing and recapping of a MALAT1 decay intermediate support the production of a previously uncharacterized micropeptide, designated MARS (MALAT1 Responsive to Stress). We further identify RNA G-quadruplex (rG4) structures in the 5' region of MALAT1 that inhibit MARS translation, revealing an additional layer of structural regulation. MARS expression increases in response to arsenite-induced oxidative stress and is associated with nuclear factor erythroid 2-related factor 2 (Nrf2)-containing complexes. Furthermore, MARS is implicated in the regulation of antioxidant response element-associated genes, including SOD and CAT, suggesting a potential role in cellular antioxidant defense. Collectively, our findings identify a previously unrecognized functional output of cytoplasmic RNA recapping and expand the potential coding repertoire of lncRNAs. This study highlights a mechanism through which cytoplasmic RNA processing may contribute to micropeptide production and suggests a role for MALAT1-derived MARS in oxidative stress-responsive gene regulation.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Mukherjee, A., Sonar, R., Mishra, P. P., Majumder, S., Mukherjee, C.. 2026-10-15. Cytoplasmic recapping commences the translation of a micropeptide, MARS from MALAT1 after the removal of an inhibitory RNA G-quadruplex. https://doi.org/10.64898/2026.10.13.758904

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

CRISPRa-mediated activation of Tfeb in a fibril-induced alpha-synuclein aggregation model

Accumulation of misfolded alpha-synuclein (a-syn) is a key hallmark of Parkinson's disease (PD), making it a key target for novel therapeutic strategies. Here, we use a previously described screening assay to select multiple efficient single guide RNA (sgRNA) combinations targeting transcription factor EB (TFEB) for CRISPR-activation (CRISPRa) using a nuclease-deficient Staphylococcus aureus Cas9 coupled to a truncated VP64-p53-Rta (VPR) activator complex. Selected sgRNA are applied in a rat neuroblastoma in-vitro model of fibril-induced a-syn aggregation with the goal of inducing autophagy and reduce protein aggregation. We successfully induce a-syn aggregation in this model and observe a stagnation in phosphorylated a-syn (p-a-syn) compared to non-phosphorylated a-syn across treatment groups. While we achieve robust expression of Tfeb in the exogenous screening assay and at endogenous mRNA level, we did not observe proportional increase in protein expression. Additionally, we do not observe any additive effects of CRISPRa induction combined with media treatments inducing Tfeb nuclear translocation. Taken together, these findings illustrate difficulties in epigenetic induction of Tfeb using CRISPRa and highlights the need for additional studies exploring this application.

molecular biology↗

cBAF drives AR-V7 expression through regulation of transcriptional termination in castration-resistant prostate cancer

The androgen receptor splice variant AR-V7 drives resistance to androgen receptor-targeted therapies in castration-resistant prostate cancer (CRPC), but the mechanisms governing its expression remain incompletely understood. Here, we identify the canonical BAF (cBAF) chromatin remodeling complex as a selective regulator of AR-V7 expression. Pharmacologic and genetic disruption of cBAF reduced AR-V7 levels, suppressed AR-V7-dependent transcriptional programs, and impaired CRPC cell proliferation. Mechanistically, cBAF binds an intronic regulatory element downstream of AR cryptic exon 3, where it maintains chromatin accessibility, enhancer activity, and promoter-enhancer looping. cBAF loss decreases recruitment of transcription termination machinery, reduces RNA polymerase II Thr4 phosphorylation, and promotes transcriptional readthrough beyond the AR-V7 polyadenylation site. POINT-seq revealed that cBAF-dependent transcriptional termination is required for AR-V7 biogenesis and regulates termination at a subset of genes genome-wide. Together, these findings uncover a role for cBAF in chromatin-mediated control of transcriptional termination and establish this mechanism as a critical determinant of AR-V7 expression.

molecular biology↗

Stage-specific checkpoint signalling by ATM, ATR and DNA-PK safeguards oocyte genome integrity

In somatic cells, DNA double-strand breaks (DSBs) are potentially catastrophic lesions that activate phosphatidylinositol 3-kinase-related kinase (PIKK) signalling to promote DNA repair or eliminate damaged cells. During meiosis, however, DSBs are deliberately generated as essential intermediates in homologous recombination, raising the question of how DNA damage signalling distinguishes programmed recombination from genome instability. To define how PIKK signalling is adapted to these distinct contexts, we resolved the function of the three PIKKs ATM, ATR and DNA-PK in physiological meiotic recombination and the response to postnatal DNA damage in mouse oocytes. Following postnatal irradiation, ATM functions as the dominant response kinase, with ATR and DNA-PK acting redundantly to eliminate damaged oocytes. In contrast, meiotic surveillance is mediated by ATR, with ATR removal rescuing oocyte loss in response to asynapsis and, independently, to persistent meiotic DSBs. Our findings demonstrate that DNA damage signalling is developmentally reconfigured during oogenesis and highlight distinct pathways of oocyte elimination that may ultimately inform strategies to maintain the ovarian reserve in mammals.

molecular biology↗